A prior report demonstrated that IL-33 alleviates hepatic steatosis in high-fat diet-induced murine MAFLD (10), while another demonstrated a harmful role in the face of diabetes and MASH (11). This evidence concerns the gene IL33 and metabolic dysfunction-associated steatohepatitis.